165 related articles for article (PubMed ID: 17047653)
1. Prognostic value of increase in transcript levels of Tp73 DeltaEx2-3 isoforms in low-grade glioma patients.
Wager M; Guilhot J; Blanc JL; Ferrand S; Milin S; Bataille B; Lapierre F; Denis S; Chantereau T; Larsen CJ; Karayan-Tapon L
Br J Cancer; 2006 Oct; 95(8):1062-9. PubMed ID: 17047653
[TBL] [Abstract][Full Text] [Related]
2. The presence of an intronic deletion in p73 and high levels of ZEB1 alter the TAp73/DeltaTAp73 ratio in colorectal carcinomas.
Domínguez G; Peña C; Silva J; García JM; García V; Rodríguez R; Cantos B; Citores MJ; España P; Bonilla F
J Pathol; 2006 Dec; 210(4):390-7. PubMed ID: 17029218
[TBL] [Abstract][Full Text] [Related]
3. DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1.
Domínguez G; García JM; Peña C; Silva J; García V; Martínez L; Maximiano C; Gómez ME; Rivera JA; García-Andrade C; Bonilla F
J Clin Oncol; 2006 Feb; 24(5):805-15. PubMed ID: 16380414
[TBL] [Abstract][Full Text] [Related]
4. Regulating p73 isoforms in human tumours.
Coates PJ
J Pathol; 2006 Dec; 210(4):385-9. PubMed ID: 17044134
[TBL] [Abstract][Full Text] [Related]
5. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.
Concin N; Becker K; Slade N; Erster S; Mueller-Holzner E; Ulmer H; Daxenbichler G; Zeimet A; Zeillinger R; Marth C; Moll UM
Cancer Res; 2004 Apr; 64(7):2449-60. PubMed ID: 15059898
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of ΔTAp73 isoform levels and their target genes in colon cancer patients.
Soldevilla B; Díaz R; Silva J; Campos-Martín Y; Muñoz C; García V; García JM; Peña C; Herrera M; Rodriguez M; Gómez I; Mohamed N; Marques MM; Bonilla F; Domínguez G
Clin Cancer Res; 2011 Sep; 17(18):6029-39. PubMed ID: 21807636
[TBL] [Abstract][Full Text] [Related]
7. Overexpressed TP73 induces apoptosis in medulloblastoma.
Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
[TBL] [Abstract][Full Text] [Related]
8. Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo.
Emmrich S; Wang W; John K; Li W; Pützer BM
Mol Cancer; 2009 Aug; 8():61. PubMed ID: 19671150
[TBL] [Abstract][Full Text] [Related]
9. Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations.
Faridoni-Laurens L; Tourpin S; Alsafadi S; Barrois M; Temam S; Janot F; Koscielny S; Bosq J; Bénard J; Ahomadegbe JC
Cell Cycle; 2008 Jun; 7(11):1587-96. PubMed ID: 18469517
[TBL] [Abstract][Full Text] [Related]
10. The TP73 complex network: ready for clinical translation in cancer?
Soldevilla B; Millán CS; Bonilla F; Domínguez G
Genes Chromosomes Cancer; 2013 Nov; 52(11):989-1006. PubMed ID: 23913810
[TBL] [Abstract][Full Text] [Related]
11. The role of the TP73 gene and its transcripts in neuro-oncology.
Jancalek R
Br J Neurosurg; 2014 Oct; 28(5):598-605. PubMed ID: 24742294
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of TP73 isoforms by 1α,25-dihydroxyvitamin D3 and survivin in human colon and breast carcinomas.
Díaz R; González-Sancho JM; Soldevilla B; Silva J; García JM; García V; Peña C; Herrera M; Gómez I; Bonilla F; Domínguez G
Genes Chromosomes Cancer; 2010 Dec; 49(12):1135-42. PubMed ID: 20842728
[TBL] [Abstract][Full Text] [Related]
13. Expression of TAP73 and DeltaNP73 in malignant gliomas.
Ugur H; Sayan AE; Ozdamar SO; Kanpolat Y; Ozturk M
Oncol Rep; 2004 Jun; 11(6):1337-41. PubMed ID: 15138575
[TBL] [Abstract][Full Text] [Related]
14. Quantitative TP73 transcript analysis in hepatocellular carcinomas.
Stiewe T; Tuve S; Peter M; Tannapfel A; Elmaagacli AH; Pützer BM
Clin Cancer Res; 2004 Jan; 10(2):626-33. PubMed ID: 14760085
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of p73-mediated regulation of hepatitis B virus core promoter/enhancer II: implications for hepatocarcinogenesis.
Buhlmann S; Racek T; Schwarz A; Schaefer S; Pützer BM
J Mol Biol; 2008 Apr; 378(1):20-30. PubMed ID: 18342333
[TBL] [Abstract][Full Text] [Related]
16. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.
Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X
Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538
[TBL] [Abstract][Full Text] [Related]
17. p73: in silico evidence for a putative third promoter region.
Sayan AE; Rossi M; Melino G; Knight RA
Biochem Biophys Res Commun; 2004 Jan; 313(3):765-70. PubMed ID: 14697257
[TBL] [Abstract][Full Text] [Related]
18. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
[TBL] [Abstract][Full Text] [Related]
19. Generation of DeltaTAp73 proteins by translation from a putative internal ribosome entry site.
Sayan AE; Roperch JP; Sayan BS; Rossi M; Pinkoski MJ; Knight RA; Willis AE; Melino G
Ann N Y Acad Sci; 2007 Jan; 1095():315-24. PubMed ID: 17404044
[TBL] [Abstract][Full Text] [Related]
20. Expression of TAp73 and DeltaNp73 isoform transcripts in thyroid tumours.
Ferru A; Denis S; Guilhot J; Gibelin H; Tourani JM; Kraimps JL; Larsen CJ; Karayan-Tapon L
Eur J Surg Oncol; 2006 Mar; 32(2):228-30. PubMed ID: 16290057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
